W. R. Berkley Corporation (WRB) Stock Price & Analysis
W. R. Berkley Corporation (WRB) closed at USD 75.55 on Thursday, October 22, 2026, up 1.63% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 74.34; the Oct 22, 2026 session ranged USD 74.62–75.88 on volume of 1,748,988 shares. Market capitalization is $28.05B, with a 52-week range of USD 62.87–78.96 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:16 UTC.
Also available as compact Markdown for AI agents: nexqual.com/WRB.md
Key facts (WRB)
- Last four reported quarters (through Jun 30, 2026): revenue $14.9B, net income $1.93B (12.9% margin) (SEC filings).
- Valuation: P/E 14.5x (avg 14.4x at the last 3 fiscal year-ends).
- 2 of 80 tracked superinvestors hold WRB (13F, Q2 2026): 0 new, 0 added, 0 reduced, 2 unchanged.
- Analysts: Hold (mean 3.44 on a 1–5 scale) (18 analysts), mean target USD 69.24 (range 51–83).
- Total return with dividends: 1Y +3.2% vs S&P 500 +14.9%; 5Y +132.8% vs S&P 500 +80.3%.
- Next earnings: 2026-10-19, EPS estimate USD 1.2, revenue estimate $3.23B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (WRB)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $9.46B | $11.2B | $12.1B | $13.6B | $14.7B | $14.9B |
| Net income | $1.02B | $1.38B | $1.38B | $1.76B | $1.78B | $1.93B |
| EPS (diluted) | $2.44 | $3.29 | $3.37 | $4.36 | $4.45 | — |
| Net margin | 10.8% | 12.4% | 11.4% | 12.9% | 12.1% | 12.9% |
| Revenue growth | +16.7% | +18.1% | +8.7% | +12.3% | +7.8% | — |
| Cash + short-term investments | $1.57B | $1.45B | $1.36B | $1.97B | $2.54B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (WRB)
P/E 14.5x · P/S 1.9x · P/B 2.9x · Earnings yield 6.87% · Dividend yield (paid, TTM) 1.71% · Buyback yield (TTM) 2.26%
P/E at fiscal year-ends: Dec 2025 15.8x, Dec 2024 13.4x, Dec 2023 14.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (WRB)
2 of 80 tracked investors hold WRB. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Bruce Berkowitz | Fairholme Capital | 1.21% | $18.1M | Unchanged |
| Thomas Gayner | Markel Group | 0.03% | $4.3M | Unchanged |
Analysts (WRB)
Consensus Hold (mean 3.44 on a 1–5 scale), 18 analysts; mean target USD 69.24 (low 51, high 83).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | Wells Fargo | Target raised | Underweight | $65 → $68 |
| 2026-10-20 | Evercore ISI Group | Target lowered | Underperform | $70 → $69 |
| 2026-10-20 | Mizuho | Target raised | Neutral | $70 → $73 |
| 2026-10-12 | Wells Fargo | Target lowered | Underweight | $68 → $65 |
| 2026-10-07 | Mizuho | Target lowered | Neutral | $72 → $70 |
| 2026-10-07 | Cantor Fitzgerald | Target raised | Neutral | $73 → $74 |
| 2026-10-06 | Morgan Stanley | Target lowered | Equal-Weight | $75 → $70 |
| 2026-09-16 | Mizuho | Target lowered | Neutral | $74 → $72 |
| 2026-07-27 | UBS | Target raised | Neutral | $71 → $77 |
| 2026-07-21 | Wells Fargo | Target raised | Underweight | $67 → $68 |
| 2026-07-21 | Truist Securities | Target raised | Buy | $78 → $83 |
| 2026-07-21 | Mizuho | Target raised | Neutral | $72 → $74 |
Total return (dividends reinvested) (WRB)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +3.2% | +132.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +3.2% | +18.4% |
| Volatility (annualized) | 22.4% | 22.0% |
| Max drawdown | -17.2% (Nov 2025→May 2026) | -25.1% (Nov 2022→May 2023) |
WRB revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Insurance | $3.17B | 85.4% | +4.5% |
| Reinsurance & Monoline Excess | $432.1M | 11.6% | -4.0% |
| Total revenue | $3.72B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
WRB company outlook (results filed Oct 19, 2026)
- “Any forward-looking statements contained herein, including statements related to our outlook for the industry and for our performance for the year 2026 and beyond, are based upon the Company's historical performance and on current plans, estimates and expectations.”
Quoted word-for-word from the SEC 8-K results press release.
WRB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $1.20 | $1.20 | +0.2% | $3.23B | 15 |
| Next quarter (ends Mar 2027) | $1.21 | $1.21 | +0.1% | $3.24B | 14 |
| Current fiscal year (ends Dec 2026) | $4.96 | $4.83 | +2.7% | $12.77B | 14 |
| Next fiscal year (ends Dec 2027) | $4.86 | $4.81 | +1.1% | $13.17B | 17 |
WRB options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 24.7% | ±6.3% |
| Dec 18, 2026 | 56 | 23.1% | ±7.4% |
| Jan 15, 2027 | 84 | 21.1% | ±8.6% |
| Apr 16, 2027 | 175 | 22.5% | ±12.6% |
30-day implied volatility 20.7% vs 19.8% realized over the last 30 trading days. Put/call ratio (volume) 0.26. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:16 UTC)
| Price | USD 75.55 |
|---|---|
| Change | ▲ 1.63% (up) |
| Previous Close | USD 74.34 |
| Open | USD 74.96 |
| Day Range | USD 74.62 – 75.88 |
| 52-Week Range | USD 62.87 – 78.96 |
| Volume | 1,748,988 shares |
| Market Cap | $28.05B |
| Exchange | NYQ |
Technical Analysis (WRB)
Nexqual's technical model rates WRB "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 09:16 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 69.01 (neutral) |
| vs SMA50 | Above (USD 70.11) |
| MACD | 1.46 (positive) |
Analyst Ratings (WRB)
Wall Street analysts rate WRB "Hold" based on 18 analysts, with a mean price target of USD 69.24 (range USD 51–83), per Nexqual as of October 23, 2026 at 09:16 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 18 |
| Mean Target | USD 69.24 |
| High Target | USD 83 |
| Low Target | USD 51 |
| Buy / Hold / Sell | 2 / 9 / 7 |
Earnings (WRB)
| Next Earnings Date | 2026-10-19 |
|---|---|
| EPS Estimate | USD 1.2 |
| Revenue Estimate | $3.23B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 1.17 vs est 1.16 ▲ beat |
| 2026-06-30 | USD 1.27 vs est 1.08 ▲ beat |
| 2026-03-31 | USD 1.3 vs est 1.14 ▲ beat |
| 2025-12-31 | USD 1.13 vs est 1.12 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
Financials & Fundamentals (WRB)
| Total Revenue | $14.87B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -0.80% |
| Gross Margin | +43.60% |
| Operating Margin | +16.07% |
| Profit Margin | +12.53% |
| Debt / Equity | 0.32 |
| Total Cash | $3.90B |
| Total Debt | $3.10B |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
Financial Health Score (WRB)
Nexqual rates W. R. Berkley Corporation's overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:16 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 16% (last 12 months) |
| Balance Sheet | Solid — $3.90B cash vs $3.10B debt, net cash position |
| Cash Flow | Solid — Operating cash flow $3.58B (FY ended Dec 2025, 10-K) |
| Efficiency | Mixed — No data |
Ownership (WRB)
| Insider Ownership | +26.35% |
|---|---|
| Institutional Ownership | +76.21% |
| Shares Outstanding | 371.23M |
| Float | 243.89M |
| Short % of Float | +5.59% |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
Leadership (WRB)
W. R. Berkley Corporation is led by William Robert Berkley, President, CEO & Chairman, per Nexqual as of October 23, 2026 at 09:16 UTC.
| President, CEO & Chairman | William Robert Berkley |
|---|---|
| Executive VP & CFO | Richard Mark Baio |
| Executive Vice President of Investments | James Gerald Shiel |
| Vice President of Investor Relations | Karen A. Horvath |
| VP & Chief Marketing Officer | Jonathan M. Levine |
Major Backers & Investors (WRB)
Notable institutional backers of W. R. Berkley Corporation include Mitsui Sumitomo Insurance Co Ltd, Morgan Stanley, Kayne Anderson Rudnick Investment Management LLC, according to Nexqual as of October 23, 2026 at 09:16 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Mitsui Sumitomo Insurance Co Ltd | 15.83% |
| Morgan Stanley | 2.22% |
| Kayne Anderson Rudnick Investment Management LLC | 1.72% |
| Invesco | 1.35% |
| Goldman Sachs | 1.12% |
| Fidelity | 1.03% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 8.95% |
| BlackRock | 5.91% |
| State Street | 3.81% |
| Geode Capital | 2.23% |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
From W. R. Berkley Corporation's Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- New York's cybersecurity regulation applies to financial services institutions authorized by the New York State Department of Financial Services (the "NYDFS"), including our insurance subsidiaries licensed in New York.
- The CPRA also established a new agency, the California Privacy Protection Agency, authorized to enforce the CCPA and promulgate regulations — including regulations that came into effect on January 1, 2026, to clarify the application of the CCPA to insurance companies.
- In each geographic region in which we operate, we have built decentralized structures that allow products and services to be tailored to each regional customer base.
Partnerships
- In order to properly match loss expenses with income earned on investment securities supporting the liabilities, reserves for excess workers' compensation business are discounted using risk-free discount rates determined by reference to the U.S.
Legal & Regulatory Risks (Item 1A, quoted)
- Our actual claims losses may exceed our reserves for claims, which may require us to establish additional reserves.
- Claims and coverage issues may emerge that extend coverage beyond our underwriting intent or increase the number and/or size of claims.
- We are exposed to, and may face adverse developments involving, mass tort claims.
- We are subject to extensive governmental regulation, which increases our costs and could restrict the conduct of our business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CINF | Cincinnati Financial Corporatio | USD 178.28 | ▲ 2.68% |
| MKL | Markel Group Inc. | USD 1,905.39 | ▲ 1.79% |
| L | Loews Corporation | USD 113.68 | ▲ 1.75% |
| AIZ | Assurant, Inc. | USD 288.85 | ▲ 1.6% |
| CNA | CNA Financial Corporation | USD 49.39 | ▲ 2.21% |
| AFG | American Financial Group, Inc. | USD 153.46 | ▲ 2.53% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:16 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt